Abstract
Clinical Outcomes of Percutaneous Intervention in Triple-Vessel and Left Main Coronary Artery Diseases
Highlights
Coronary artery disease (CAD) remains one of the most important diseases because of its high morbidity and mortality.[1]
The rates of cardiovascular events were low, indicating that percutaneous coronary intervention (PCI) may be an acceptable alternative in selected cases. (Int J Cardiovasc Sci. 2016;29(4):262-269)
Preventive measures such as lifestyle changes, modification of risk factors, improvements in medical therapy, and advances in coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) have resulted in a reduction in mortality related to cardiovascular diseases.[2]
Summary
Coronary artery disease (CAD) remains one of the most important diseases because of its high morbidity and mortality.[1] preventive measures such as lifestyle changes, modification of risk factors, improvements in medical therapy, and advances in coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) have resulted in a reduction in mortality related to cardiovascular diseases.[2]. Myocardial revascularization in triple-vessel and left main coronary artery (LMCA) diseases can be performed by percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
